Uptake and fate of ganglioside GD3 in human intestinal Caco-2 cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 297, Issue 1, 2009, Pages

  Schnabl, Kareena L ^a   Larcelet, Marjorie ^b   Thomson, Alan B R ^a   Clandinin, Michael T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Apical; Basolateral membrane; Brush border membrane

Indexed keywords

GANGLIOSIDE GD3;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; BRUSH BORDER; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE CELL; LIPID ABSORPTION; LIPID METABOLISM; LIPID TRANSPORT; PRIORITY JOURNAL; TIME;

BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; CACO-2 CELLS; CELL POLARITY; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROCYTES; GANGLIOSIDES; HUMANS; KINETICS; NECROSIS;

EID: 67650069645     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90599.2008     Document Type: Article

References (64)

1. Albrecht B, Pohlentz G, Sandhoff K, Schwarzmann G. Synthesis and mass spectrometric characterization of digoxigenin and biotin labeled ganglioside GM1 and their uptake by and metabolism in cultured cells. Chem Phys Lipids 86: 37-50, 1997.
2. Allende ML, Proia RL. Lubricating cell signaling pathways with gangliosides. Curr Opin Struct Biol 12: 587-592, 2002.
3. Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, and Graziano MP. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303: 1201-1204, 2004.
4. Berra B, Colombo I, Monteggia E, Montorfano G, Moretti S, Rapelli S, Sottocornola E. Glycosphingolipid expression in solid tumours and transformed cell lines. Indian J Biochem Biophys 34: 170-177, 1997.
5. Bieberich E. Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: review and hypothesis. Glycoconj J 21: 315-327, 2004.
6. Bietrix F, Yan D, Nauze M, Rolland C, Bertrand-Michel J, Comera C, Schaak S, Barbaras R, Groen AK, Perret B, Terce F, Collet X. Accelerated lipid absorption in mice overexpressing intestinal SR-BI. J Biol Chem 281: 7214-7219, 2006.
7. Blomqvist M, Osterbye T, Mansson JE, Buschard K, Fredman P. Uptake of the glycosphingolipid sulfatide in the gastrointestinal tract and pancreas in vivo and in isolated islets of Langerhans. Lipids Health Dis 5: 26, 2006.
8. Bode L, Beermann C, Mank M, Kohn G, Boehm G. human and bovine milk gangliosides differ in their fatty acid composition. J Nutr 134: 3016-3020, 2004.
9. Boltz-Nitulescu G, Ortel B, Riedl M, Forster O. Ganglioside receptor of rat macrophages. Modulation by enzyme treatment and evidence for its protein nature. Immunology 51: 177-184, 1984.
10. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res 48: 1936-1942, 1988.
11. Chantret I, Rodolosse A, Barbat A, Dussaulx E, Brot-Laroche E, Zweibaum A, Rousset M. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J Cell Sci 107: 213-225, 1994.
12. Choudhury A, Marks DL, Proctor KM, Gould GW, REP. Regulation of caveolar endocytosis by syntaxin 6-dependent delivery of membrane components to the cell surface. Nat Cell Biol 8: 317-328, 2006.
13. Clarke JT. The glycosphingolipids of human plasma lipoproteins. Can J Biochem 59: 412-417, 1981.
14. Dahiya R, Brasitus TA. Distribution of glycosphingolipids and ceramide of rat small intestinal mucosa. Lipids 21: 112-116, 1986.
15. Draper JS, Pigott C, Thomson JA, Andrews PW. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 200: 249-258, 2002.
16. 3H]- sphingosine-GM1 after intravenous injection in rats. Biochem Biophys Res Commun 189: 1410-1416, 1992.
17. Fantini J, Maresca M, Hammache D, Yahi N, Delezay O. Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion. Glycoconj J 17: 173-179, 2000.
18. Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 18: 479-497, 2003.
19. Folch J, Lees M, Sloane Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1957.
20. Forstner GG, Wherrett JR. Plasma membrane and mucosal glycosphingolipids in the rat intestine. Biochim Biophys Acta 306: 446-459, 1973.
21. Garuti R, Jones C, Li WP, Michaely P, Herz J, Gerard RD, Cohen JC, Hobbs HH. The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits. J Biol Chem 280: 40996-41004, 2005.
22. Hakomori S. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 265: 18713-18716, 1990.
23. Harris DS, Slot JW, Geuze HJ, James DE. Polarized distribution of glucose transporter isoforms in Caco-2 cells. Proc Natl Acad Sci USA 89: 7556-7560, 1992.
24. Kniep B, Kniep E, Ozkucur N, Barz S, Bachmann M, Malisan F, Testi R, Rieber EP. 9-O-acetyl GD3 protects tumor cells from apoptosis. Int J Cancer 119: 67-73, 2006.
25. Ladisch S, Gillard B, Wong C, Ulsh L. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res 43: 3808-3813, 1983.
26. Lauc G, Heffer-Lauc M. Shedding and uptake of gangliosides and glycosylphosphatidylinositol-anchored proteins. Biochim Biophys Acta 1760: 584-602, 2006.
27. Ledeen RW, Wu G. Ganglioside function in calcium homeostasis and signaling. Neurochem Res 27: 637-647, 2002.
28. Leskawa KC, Erwin RE, Leon A, Toffano G, Hogan EL. Incorporation of exogenous ganglioside GM1 into neuroblastoma membranes: inhibition by calcium ion and dependence upon membrane protein. Neurochem Res 14: 547-554, 1989.
29. Liu F, Cheng Y, Wu J, Tauschel HD, Duan RD. Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells. Cancer Lett 235: 141-146, 2006.
30. Malinina L, Malakhova ML, Kanack AT, Lu M, Abagyan R, Brown RE, Patel DJ. The liganding of glycolipid transfer protein is controlled by glycolipid acyl structure. PLoS Biol 4: e362, 2006.
31. Malisan F, Testi R. The ganglioside GD3 as the Greek goddess Hecate: several faces turned towards as many directions. IUBMB Life 57: 477-482, 2005.
32. Martel F, Goncalves P, Azevedo I. Absorption of folate by Caco-2 cells is not affected by high glucose concentration. Eur J Pharmacol 551: 19-26, 2006.
33. Merrill AH Jr, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Riley RT, Voss KA, Wang E. Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 142: 208-225, 1997.
34. Midorikawa M, Inui K, Okada S, Yabuuchi H, Ogura K, Handa S. Uptake and metabolism of radiolabelled GM1-ganglioside in skin fibroblasts from controls and patients with GM1-gangliosidosis. J Inherit Metab Dis 14: 721-729, 1991.
35. Milis DG, Moore MK, Atshaves BP, Schroeder F, Jefferson JR. Sterol carrier protein-2 expression alters sphingolipid metabolism in transfected mouse L-cell fibroblasts. Mol Cell Biochem 283: 57-66, 2006.
36. Morales A, Colell A, Mari M, Garcia-Ruiz C, Fernandez-Checa J. Glycosphingolipids and mitochondria: role in apoptosis and disease. Glycoconj J 20: 579-588, 2004.
37. Moss J, Fishman PH, Manganiello VC, Vaughan M, Brady RO. Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness. Proc Natl Acad Sci USA 73: 1034-1037, 1976.
38. Munford RS. Detoxifying endotoxin: time, place and person. J Endotoxin Res 11: 69-84, 2005.
39. Nichols B. Caveosomes and endocytosis of lipid rafts. J Cell Sci 116: 4707-4714, 2003.
40. Nilsson A, Duan RD. Absorption and lipoprotein transport of sphingomyelin. J Lipid Res 47: 154-171, 2006.
41. Oram JF, Vaughan AM. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ Res 99: 1031-1043, 2006.
42. Pagano RE. Lipid traffic in eukaryotic cells: mechanisms for intracellular transport and organelle-specific enrichment of lipids. Curr Opin Cell Biol 2: 652-663, 1990.
43. Park EJ, Suh M, Ramanujam K, Steiner K, Begg D, Clandinin MT. Diet-induced changes in membrane gangliosides in rat intestinal mucosa, plasma and brain. J Pediatr Gastroenterol Nutr 40: 487-495, 2005.
44. Park EJ, Suh M, Thomson AB, Ramanujam KS, Clandinin MT. Dietary gangliosides increase the content and molecular percentage of ether phospholipids containing 20:4n-6 and 22:6n-3 in weanling rat intestine. J Nutr Biochem 17: 337-344, 2006.
45. Peterson MD, Bement WM, Mooseker MS. An in vitro model for the analysis of intestinal brush border assembly. II. Changes in expression and localization of brush border proteins during cell contact-induced brush border assembly in Caco-2BBe cells. J Cell Sci 105: 461-472, 1993.
46. 3H]- gangliosides by an intestinal protozoan, Giardia lamblia. Parasitol Res 96: 102-106, 2005.
47. Raggers RJ, van Helvoort A, Evers R, van Meer G. The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J Cell Sci 112: 415-422, 1999.
48. Reboul E, Thap S, Perrot E, Amiot MJ, Lairon D, Borel P. Effect of the main dietary antioxidants (carotenoids, gamma-tocopherol, polyphenols, and vitamin C) on alpha-tocopherol absorption. Eur J Clin Nutr 61: 1167-1173, 2007.
49. Rensen PC, van Leeuwen SH, Sliedregt LA, van Berkel TJ, Biessen EA. Design and synthesis of novel N-acetylgalactosamine-terminated glycolipids for targeting of lipoproteins to the hepatic asialoglycoprotein receptor. J Med Chem 47: 5798-5808, 2004.
50. Rueda R, Maldonado J, Narbona E, Gil A. Neonatal dietary gangliosides. Early Hum Dev 53 Suppl: S135-S147, 1998.
51. Sagiv Y, Hudspeth K, Mattner J, Schrantz N, Stern RK, Zhou D, Savage PB, Teyton L, Bendelac A. Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J Immunol 177: 26-30, 2006.
52. Sane AT, Sinnett D, Delvin E, Bendayan M, Marcil V, Menard D, Beaulieu JF, Levy E. Localization and role of NPC1L1 in cholesterol absorption in human intestine. J Lipid Res 47: 2112-2120, 2006.
53. Saqr HE, Pearl DK, Yates AJ. A review and predictive models of ganglioside uptake by biological membranes. J Neurochem 61: 395-411, 1993.
54. Schmelz EM, Crall KJ, Larocque R, Dillehay DL, Merrill AH Jr. Uptake and metabolism of sphingolipids in isolated intestinal loops of mice. J Nutr 124: 702-712, 1994.
55. Schwarzmann G. Uptake and metabolism of exogenous glycosphingolipids by cultured cells. Semin Cell Dev Biol 12: 163-171, 2001.
56. Shen Y, Tiralongo J, Kohla G, Schauer R. Regulation of sialic acid O-acetylation in human colon mucosa. Biol Chem 385: 145-152, 2004.
57. Spiegel S, Blumenthal R, Fishman PH, Handler JS. Gangliosides do not move from apical to basolateral plasma membrane in cultured epithelial cells. Biochim Biophys Acta 821: 310-318, 1985.
58. Sugawara T, Kinoshita M, Ohnishi M, Nagata J, Saito M. Digestion of maize sphingolipids in rats and uptake of sphingadienine by Caco-2 cells. J Nutr 133: 2777-2782, 2003.
59. Suh M, Belosevic M, Clandinin MT. Dietary lipids containing gangliosides reduce Giardia muris infection in vivo and survival of Giardia lamblia trophozoites in vitro. Parasitology 128: 595-602, 2004.
60. Tettamanti G. Ganglioside/glycosphingolipid turnover: new concepts. Glycoconj J 20: 301-317, 2004.
61. Vesper H, Schmelz EM, Nikolova-Karakashian MN, Dillehay DL, Lynch DV, Merrill AH Jr. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 129: 1239-1250, 1999.
62. Wang JH, Huang ZM, Wu JS, Chen XR, Jin SQ, Huang QK, Wang D. [Ganglioside GD3 enhances the anti-tumor effect of doxorubicin on hepatoma cells]. Zhonghua Gan Zang Bing Za Zhi 14: 710-711, 2006.
63. Williams M, McCluer R. The use of Sep-Pak C18 cartridges during the isolation of gangliosides. J Neurochem 35: 266-269, 1980.
64. Yoshiizumi K, Nakajima F, Dobashi R, Nishimura N, Ikeda S. Studies on scavenger receptor inhibitors. Part 1: synthesis and structure-activity relationships of novel derivatives of sulfatides. Bioorg Med Chem 10: 2445-2460, 2002.